Skip to main content

Alopecia News (Page 2)

Related terms: Alopecia Areata, Balding, Baldness, Baldness, female pattern, Hair Loss, Hairloss, Hair Thinning, Loss of Hair

FDA Approves Leqselvi for Severe Alopecia

FRIDAY, Aug. 2, 2024 – The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata. Leqselvi (8 mg) is a twice-daily...

FDA Approves Leqselvi (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

MUMBAI, India and PRINCETON, N.J., July 26, 2024 /PRNewswire/ – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its...

FDA Approves Litfulo (ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata

NEW YORK--(BUSINESS WIRE) June 23, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Litfulo™ (ritlecitinib), a once-daily oral treatment, f...

FDA Approves Lilly and Incyte's Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata

INDIANAPOLIS, June 13, 2022 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved Olumiant...

FDA Medwatch Alert: Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards

Men's Minoxidil 15% Azelaic 5% Hair regrowth topical, 60ml Men's Minoxidil 10% Azelaic 5% Hair regrowth topical, 60mL Men's Minoxidil 5% Azelaic 5% Hair regrowth topical, 60mL Women's Minoxidil 3%...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

spironolactone, triamcinolone, Rogaine, minoxidil